Description
Trade name:
Ultrasolv
Compound:
Each tablet contains:
Carbocisteine 375 mg
Guaiphenazine 225 mg
Oxomemazine hydrochloride 5 mg
Auxiliary components:
Avicel, crospovidone, calcium phosphate dibasic, talc, magnesium stearate, ethanol.
Properties:
Carbocisteine is a mucolytic and expectorant drug. The mucolytic and expectorant effect is due to the activation of sialic transferase, an enzyme of goblet cells of the bronchial mucosa. Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretions. Reduces the viscosity of bronchial secretions and secretions from the paranasal sinuses, facilitates the discharge of sputum and mucus, reduces cough. Promotes the regeneration of the mucous membrane, normalizes its structure, activates the activity of the ciliated epithelium. Restores the secretion of immunoglobulin IgA (specific protection) and the number of sulfhydryl groups of mucus components (non-specific protection), improves mucociliary clearance.
Guaiphenazine – increases the activity of the ciliated epithelium, increases the secretion of liquid components of bronchial mucus due to the depolymerization of acidic polysaccharides. Increases the volume of sputum, reducing its viscosity and facilitating its evacuation from the respiratory tract.
Oxomemazine is an H1 antihistamine. It is intended to relieve allergic cough.
Indications:
– acute and chronic bronchopulmonary diseases accompanied by the formation of viscous, difficult to separate sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis);
– inflammatory diseases of the middle ear (otitis media);
-inflammatory diseases of the nose and paranasal sinuses (rhinitis, sinusitis);
– allergic bronchitis;
– preparation for bronchoscopy and/or bronchography.
Method of administration and dosage:
Adults:
7.5 ml of syrup or 1 tablet 2-3 times a day.
Contraindications:
– hypersensitivity to carbocysteine and other components of the drug;
– gastric ulcer and duodenal ulcer in the acute phase;
chronic glomerulonephritis in the acute phase;
– children under 6 years of age.
Precautions:
In patients with a history of peptic ulcer, the dose should be reduced. Treatment can be combined with physiotherapy.
Impact on the ability to drive vehicles and operate machinery:
The effect of the drug on the ability to drive vehicles and perform work requiring high concentration and speed of psychomotor reactions has not been studied.
Side effects:
From the digestive system: sometimes – nausea, vomiting, diarrhea, epigastric pain, gastrointestinal bleeding.
Allergic reactions: in isolated cases – skin itching, urticaria, exanthema, angioedema.
Others: dizziness, weakness, malaise.
In patients with bronchial asthma and in elderly patients, airway obstruction may occur.
Storage method:
At a temperature not exceeding 30 degrees.
Package:
The cardboard box contains a blister of 10 tablets and paper instructions.
